India allows Serum Institute to enrol 7-11 year olds in Novavax COVID-19 vaccine trial

BENGALURU (Reuters) -India's drug regulator on Tuesday allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of U.S. drugmaker Novavax's COVID-19 vaccine, as the country…

Covid-19: No newborn calf serum in final Covaxin product, says Health ministry, Bharat Biotech

New Delhi [India], June 16 (ANI): The Union Health Ministry on Wednesday said that newborn calf serum is not an ingredient of the final Covaxin vaccine by Bharat Biotech. The…